| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Adoptive transfer of Pfkfb3-disrupted hematopoietic cells to wild-type mice exacerbates diet-induced hepatic steatosis and inflammation
|
Guo, Xin
|
|
|
|
3 |
p. 136-144
|
artikel
|
| 2 |
Autophagy in ischemic aged livers
|
Lee, Choonghee
|
|
2018
|
|
3 |
p. 133-137
|
artikel
|
| 3 |
Autophagy in liver diseases: A matter of what to remove and whether to keep
|
Yin, Xiao-Ming
|
|
2018
|
|
3 |
p. 109-111
|
artikel
|
| 4 |
Autophagy in non-alcoholic fatty liver disease and alcoholic liver disease
|
Khambu, Bilon
|
|
2018
|
|
3 |
p. 112-119
|
artikel
|
| 5 |
Berberine enhances the anti-hepatocellular carcinoma effect of NK92-MI cells through inhibiting IFN-gamma-mediated PD-L1 expression
|
Wang, Kunyuan
|
|
|
|
3 |
p. 167-174
|
artikel
|
| 6 |
Bile acid activated receptors: Integrating immune and metabolic regulation in non-alcoholic fatty liver disease
|
Biagioli, Michele
|
|
|
|
3 |
p. 119-141
|
artikel
|
| 7 |
Bile acid metabolism and bile acid receptor signaling in metabolic diseases and therapy
|
Chiang, John Y.L.
|
|
|
|
3 |
p. 103-104
|
artikel
|
| 8 |
Bile acid receptors and signaling crosstalk in the liver, gut and brain
|
Ferrell, Jessica M.
|
|
|
|
3 |
p. 105-118
|
artikel
|
| 9 |
Bile acids and metabolic surgery
|
Xue, Hui
|
|
|
|
3 |
p. 164-170
|
artikel
|
| 10 |
B lymphocyte-mediated humoral immunity in the pathogenesis of chronic hepatitis B infection
|
Pan, Jing
|
|
|
|
3 |
p. 124-128
|
artikel
|
| 11 |
Circadian rhythms and inflammatory diseases of the liver and gut
|
Ferrell, Jessica M.
|
|
|
|
3 |
p. 196-206
|
artikel
|
| 12 |
Clinical characteristics and risk factors of hepatitis B virus-related cirrhosis/hepatocellular carcinoma: A single-center retrospective study
|
Chen, Feng
|
|
|
|
3 |
p. 237-243
|
artikel
|
| 13 |
COVID-19 associated liver injury: An updated review on the mechanisms and management of risk groups
|
Shi, Yue
|
|
|
|
3 |
p. 207-215
|
artikel
|
| 14 |
Decoding the role of extracellular vesicles in liver diseases
|
Deng, Fengyan
|
|
2017
|
|
3 |
p. 147-155
|
artikel
|
| 15 |
Discordance among aggressiveness characteristics of hepatocellular carcinoma: Portal vein thrombosis and multifocality, related to tumor size, but not to serum alpha-fetoprotein level
|
Carr, Brian I.
|
|
|
|
3 |
p. 256-262
|
artikel
|
| 16 |
Dynactin 2 acts as an oncogene in hepatocellular carcinoma through promoting cell cycle progression
|
Li, Wenchao
|
|
|
|
3 |
p. 155-166
|
artikel
|
| 17 |
Editorial Board
|
|
|
|
|
3 |
p. ii
|
artikel
|
| 18 |
Editorial Board
|
|
|
2018
|
|
3 |
p. ii
|
artikel
|
| 19 |
Editorial Board
|
|
|
|
|
3 |
p. ii
|
artikel
|
| 20 |
Editorial Board
|
|
|
|
|
3 |
p. ii
|
artikel
|
| 21 |
Editorial Board
|
|
|
|
|
3 |
p. ii
|
artikel
|
| 22 |
Efficacy and safety of low-dose rifampicin in patients with benign intrahepatic cholestasis
|
Guo, Xiaoyan
|
|
|
|
3 |
p. 181-185
|
artikel
|
| 23 |
Erratum regarding missing declaration of competing interest statements in previously published articles
|
|
|
|
|
3 |
p. 272-273
|
artikel
|
| 24 |
Exhaled volatile organic compounds for cholangiocarcinoma diagnosis
|
Siriwong, Nanicha
|
|
|
|
3 |
p. 191-197
|
artikel
|
| 25 |
Exosomes as mediators of tumor immune escape and immunotherapy in hepatocellular carcinoma
|
Guan, Ming-Cheng
|
|
|
|
3 |
p. 132-138
|
artikel
|
| 26 |
Expert consensus on liver transplantation perioperative evaluation and rehabilitation for acute-on-chronic liver failure
|
Lv, Haijin
|
|
|
|
3 |
p. 121-129
|
artikel
|
| 27 |
Farnesoid X receptor and fibroblast growth factor 15/19 as pharmacological targets
|
Maliha, Syeda
|
|
|
|
3 |
p. 142-150
|
artikel
|
| 28 |
FOXO transcription factors in non-alcoholic fatty liver disease
|
Dong, X. Charlie
|
|
2017
|
|
3 |
p. 168-173
|
artikel
|
| 29 |
Glycogen accumulation drives hepatocarcinogenesis by targeting the Hippo signaling pathway
|
Liang, Weicheng
|
|
|
|
3 |
p. 198-200
|
artikel
|
| 30 |
Gut microbiome in liver pathophysiology and cholestatic liver disease
|
Yan, Shengmin
|
|
|
|
3 |
p. 151-163
|
artikel
|
| 31 |
Impact of antibiotics on the efficacy of immune checkpoint inhibitors in the treatment of primary liver cancer
|
Wang, Jia-Ren
|
|
|
|
3 |
p. 175-180
|
artikel
|
| 32 |
Interaction between stress responses and circadian metabolism in metabolic disease
|
Yang, Zhao
|
|
2017
|
|
3 |
p. 156-162
|
artikel
|
| 33 |
Interleukin-22 in the pathogenesis and potential treatment of liver diseases
|
Yin, Shi
|
|
2017
|
|
3 |
p. 181-185
|
artikel
|
| 34 |
Liver retransplants using living donors: An approach for management
|
Al Harakeh, Hasan
|
|
|
|
3 |
p. 252-255
|
artikel
|
| 35 |
Long non-coding RNA in liver metabolism and disease: Current status
|
Zhao, Yulan
|
|
2017
|
|
3 |
p. 163-167
|
artikel
|
| 36 |
Mechanisms of the autophagosome-lysosome fusion step and its relation to non-alcoholic fatty liver disease
|
Hikita, Hayato
|
|
2018
|
|
3 |
p. 120-124
|
artikel
|
| 37 |
Metformin alleviates cholestasis-associated nephropathy through regulating oxidative stress and mitochondrial function
|
Ommati, Mohammad Mehdi
|
|
|
|
3 |
p. 171-180
|
artikel
|
| 38 |
Microbial transformations of bile acids and their receptors in the regulation of metabolic dysfunction-associated steatotic liver disease
|
Gao, Yuhua
|
|
|
|
3 |
p. 165-176
|
artikel
|
| 39 |
Mitigation of cholestasis-associated hepatic and renal injury by edaravone treatment: Evaluation of its effects on oxidative stress and mitochondrial function
|
Ommati, Mohammad Mehdi
|
|
|
|
3 |
p. 181-193
|
artikel
|
| 40 |
Mitophagy in hepatocytes: Types, initiators and role in adaptive ethanol metabolism
|
Lemasters, John J.
|
|
2018
|
|
3 |
p. 125-132
|
artikel
|
| 41 |
Multidisciplinary, three-dimensional and individualized comprehensive treatment for severe/critical COVID-19
|
|
|
|
|
3 |
p. 109-117
|
artikel
|
| 42 |
Non-alcoholic fatty liver disease: Dietary and nutraceutical approaches
|
Cogorno, Ludovica
|
|
|
|
3 |
p. 216-227
|
artikel
|
| 43 |
Optimal use of red cell volume distribution width-to-platelet ratio to exclude cirrhosis in patients with chronic hepatitis B
|
Yu, Hongsheng
|
|
|
|
3 |
p. 244-251
|
artikel
|
| 44 |
Optimization of high throughput spectral flow cytometry for immune cell profiling in mouse liver
|
Way, Grayson W.
|
|
|
|
3 |
p. 263-271
|
artikel
|
| 45 |
Platelets: A review of their function and effects in liver diseases
|
Chen, Haoqi
|
|
|
|
3 |
p. 129-135
|
artikel
|
| 46 |
Pre-treatment twice with liposomal clodronate protects against acetaminophen hepatotoxicity through a pre-conditioning effect
|
Clemens, Melissa M.
|
|
|
|
3 |
p. 145-152
|
artikel
|
| 47 |
Prolonged existence of SARS-CoV-2 RNAs in the extracellular vesicles of respiratory specimens from patients with negative reverse transcription-polymerase chain reaction
|
Subudhi, P. Debishree
|
|
|
|
3 |
p. 228-236
|
artikel
|
| 48 |
Real-world effectiveness and safety of OBT/PTV/r and dasabuvir for patients with chronic HCV genotype 1b infection in China: A multicenter prospective observational study
|
Jie, Yusheng
|
|
|
|
3 |
p. 153-158
|
artikel
|
| 49 |
Recent development and gene therapy for glycogen storage disease type Ia
|
Chou, Janice Y.
|
|
2017
|
|
3 |
p. 174-180
|
artikel
|
| 50 |
Regulation of the homeostasis of hepatic endoplasmic reticulum and cytochrome P450 enzymes by autophagy
|
Ma, Xiaowen
|
|
2018
|
|
3 |
p. 138-145
|
artikel
|
| 51 |
Retinoic acid signaling in fatty liver disease
|
Cassim Bawa, Fathima N.
|
|
|
|
3 |
p. 189-195
|
artikel
|
| 52 |
Small-molecule chemical probes for the potential therapeutic targets in alcoholic liver diseases
|
Dogra, Ashish
|
|
|
|
3 |
p. 177-188
|
artikel
|
| 53 |
Subversion of cellular autophagy during virus infection: Insights from hepatitis B and hepatitis C viruses
|
Khan, Mohsin
|
|
2018
|
|
3 |
p. 146-156
|
artikel
|
| 54 |
Telehealth interventions for alcohol use disorder: A systematic review
|
Kelemen, Arpad
|
|
|
|
3 |
p. 146-154
|
artikel
|
| 55 |
The progress of epigenetics in the development and progression of non-alcoholic fatty liver disease
|
Xu, Fen
|
|
|
|
3 |
p. 118-123
|
artikel
|
| 56 |
The role of roof plate-specific spondins in liver homeostasis and disease
|
Yang, Le
|
|
|
|
3 |
p. 139-145
|
artikel
|
| 57 |
The S267F variant of sodium taurocholate co-transporting polypeptide is strongly associated with resistance to chronic hepatitis B and high level of serum total bile acids
|
Huang, Jiancheng
|
|
|
|
3 |
p. 186-190
|
artikel
|
| 58 |
Tumor-suppressing effects of autophagy on hepatocellular carcinoma
|
Pang, Lijun
|
|
2018
|
|
3 |
p. 157-160
|
artikel
|
| 59 |
Wu Mengchao: A blade warrior against liver cancer
|
Yang, Tian
|
|
|
|
3 |
p. 130-131
|
artikel
|
Tijdschrift beschrijving